- 流行病学研究实例(第五卷)
- 詹思延主编
- 1640字
- 2025-03-15 04:45:15
参考文献
[1]DANTAS T F,CHOMEL B B,OTRANTO D. Ticks and tick-borne diseases:a One Health perspective[J]. Trends Parasitol,2012,28(10):437-446.
[2]Kilpatrick A M,Randolph S E. Drivers,dynamics,and control of emerging vector-borne zoonotic diseases. Lancet,2012,380(9857):1946-1955.
[3]GOODMAN J L,NELSON C,VITALE B,et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis[J]. N Engl J Med,1996,334(4):209-215.
[4]CHOCHLAKIS D,IOANNOU I,TSELENTIS Y,et al. Human anaplasmosis and Anaplasma ovis variant[J]. Emerg Infect Dis,2010,16(6):1031-1032.
[5]LI H,ZHENG Y C,MA L,et al. Human infection with a novel tick-borne Anaplasma species in China:a surveillance study[J]. Lancet Infect Dis,2015,15(6):663-670.
[6]PAROLA P,PADDOCK C D,SOCOLOVSCHI C,et al. Update on tick-borne rickettsioses around the world:a geographic approach[J]. Clin Microbiol Rev,2013,26(4):657-702.
[7]LEE F S,CHU F K,TACKLEY M,et al. Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year old woman[J]. Clin Infect Dis,2000,31(5):1288-1291.
[8]BULLER R S,ARENS M,HMIEL S P,et al. Ehrlichia ewingii,a newly recognized agent of human ehrlichiosis[J]. N Engl J Med,1999,341(3):148-155.
[9]PRITT B S,SLOAN L M,JOHNSON D K,et al. Emergence of a new pathogenic Ehrlichia species,Wisconsin and Minnesota,2009[J]. N Engl J Med,2011,365(5):422-429.
[10]JIANG J F,JIANG B G,YU J H,et al. Anaplasma phagocytophilum infection in ticks,China-Russia border[J]. Emerg Infect Dis,2011,17(5):932-994.
[11]RIKIHISA Y. Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum[J]. Clin Microbiol Rev,2011,24(3):469-489.
[12]MUNDERLOH U G,LYNCH M J,HERRON M J,et al. Infection of endothelial cells with Anaplasma marginale and A.phagocytophilum[J]. Vet Microbiol,2004,101(1):53-64.
[13]BLOUIN E F,KOCAN K M,MURPHY G L,et al. Persistence of tick derived Anaplasma marginale in cultured bovine turbinate and endothelial cells[J]. Rev Elev Med Vet Pays Trop,1993,46(1-2):49-56.
[14]VANNIER E,KRAUSE P J. Human babesiosis[J]. N Engl J Med,2012,366(25):2397-2407.
[15]HERWALDT B L,LINDEN J V,BOSSERMAN E,et al. Transfusion-associated babesiosis in the United States:a description of cases[J]. Ann Intern Med,2011,155(8):509-519.
[16]JONES K E,PATEL N G,LEVY M A,et al. Global trends in emerging infectious diseases[J]. Nature,2008,451(7181):990-993.
[17]CDC. Babesiosis surveillance_18 States,2011[J]. Morb Mortal Wkly Rep,2012,61(27):505-509.
[18]HERWALDT B L,CACCIO S,GHERLINZONI F,et al. Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe[J]. Emerg Infect Dis,2003,9(8):942-948.
[19]HASELBARTH K,TENTER A M,BRADE V,et al. First case of human babesiosis in Germany-clinical presentation and molecular characterisation of the pathogen[J]. Int J Med Microbiol,2007,297(3):197-204.
[20]BLUM S,GATTRINGER R,HASCHKE E,et al. The case:hemolysis and acute renal failure[J]. Kidney Int,2011,80(6):681-683.
[21]YAO L N,RUAN W,ZENG C Y,et al. Pathogen identification and clinical diagnosis for one case infected with Babesia[J]. Chin J Parasitol Parasit Dis,2012,30(2):21.
[22]ZHOU X N,LI S G,CHEN S B,et al. Co-infections with Babesia microti and plasmodium parasites along the China-Myanmar border[J]. Infect Dis Poverty,2013,2(1):24.
[23]QI C,ZHOU D,LIU J,et al. Detection of Babesia divergens using molecular methods in anemic patients in Shandong Province,China[J]. Parasitol Res,2011,109(1):4241-4245.
[24]SUN Y,LI SG,JIANG JF,et al. Babesia venatorum infection in child,China[J]. Emerg Infect Dis,2014,20(5):896-897.
[25]RUEBUSH T K,JURANEK D D,CHISHOLM E S,et al. Human babesiosis on Nantucket Island. Evidence for self-limited and subclinical infections[J]. N Engl J Med,1977,297(15):825-827.
[26]GRAY J,ZINTL A,HILDEBRANDT A,et al. Zoonotic babesiosis:overview of the disease and novel aspects of pathogen identity[J]. Ticks Tick Borne Dis,2010,1(1):3-10.
[27]PICCALUGA P P,POLETTI G,MARTINELLI G,et al. Babesia infection in Italy[J]. Lancet Infect Dis,2004,4(4):212.
[28]WORMSER G P,DATTWYLER R J,SHAPIRO E D,et al. The clinical assessment,treatment,and prevention of Lyme disease,human granulocytic anaplasmosis,and babesiosis:clinical practice guidelines by the Infectious Diseases Society of America[J]. Clin Infect Dis,2006,43(9):1089-1134.
[29]KRAUSE P J,LEPOER T,SIKAND V K,et al. Atovaquone and azithromycin for the treatment of babesiosis[J]. N Engl J Med,2000,343(20):1454-1458.
[30]JIANG J F,ZHENG Y C,JIANG R R,et al. Epidemiological,clinical,and laboratory characteristics of 48 cases of“Babesia venatorum”infection in China:a descriptive study[J]. Lancet Infect Dis,2015,15(2):196-203.
[31]BARBOUR A G,FISH D. The biological and social phenomenon of Lyme disease[J]. Science,1993,260(5114):1610-1616.
[32]LEVI T,KILPATRICK A M,MANGEL M,et al. Deer,predators,and the emergence of Lyme disease[J]. Proc Natl Acad Sci USA,2012,109(27):10942-10947.
[33]LIU J,LI S,OUYANG Z,et al. Ecological and socioeconomic effects of China’s policies for ecosystem services[J]. Proc Natl Acad Sci USA,2008,105(28):9477-9482.
[34]LIU K,CUI N,FANG L Q,et al. Epidemiologic features and environmental risk factors of severe fever with thrombocytopenia syndrome,Xinyang,China[J]. PLoS Negl Trop Dis,2014,8(5):e2820.
[35]USPENSKY I. Tick pests and vectors(Acari:Ixodoidea)in European towns:introduction,persistence and management[J]. Ticks Tick Borne Dis,2014,5(1):41-47.
[36]GONG P,LIANG S,CARLTON E J,et al. Urbanisation and health in China[J]. Lancet,2012,379(9818):843-852.
[37]KILPATRICK A M,RANDOLPH S E. Drivers,dynamics,and control of emerging vector-borne zoonotic diseases[J]. Lancet,2012,380(9857):1946-1955.
[38]ALTIZER S,OSTFELD R S,JOHNSON P T,et al. Climate change and infectious diseases:from evidence to a predictive framework[J]. Science,2013,341(6145):514-519.
[39]HARRUS S,BANETH G. Drivers for the emergence and re-emergence of vector-borne protozoal and bacterial diseases[J]. Int J Parasitol,2005,35(11-12):1309-1318.
[40]FANG L Q,LIU K,LI X L,et al. Emerging tick-borne infections in mainland China:an increasing public health threat[J]. Lancet Infect Dis,2015,15(12):1467-1479.